Articles by Jill Van Den Bos - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jill Van Den Bos

Jill Van Den Bos


Formulary Additions: The Big Picture
October 1, 2005

To get along with the CFO, drug companies need to express more data in units that a health plan can integrate into its own internal actuarial analysis. The financial decision makers at a health plan want to know how a new drug affects the value of expected claims on the whole.

ADVERTISEMENT

Click here